RE-BVS – Piemonte Repository

Sfoglia per AUTORE
MORO G
Collezione ASL Biella

Items : 7

Predicting recurrence after 3DC Radiotherapy for prostate cancer: Proposal for a new classifier in Radiotherapy and Oncology

2016
ASL Torino 4
ASL Biella

Gabriele P; Jereczek-Fossa B; Krengli M; Garibaldi E; Tessa M; Moro G; Girelli G; Bona C; Balcet V; Ferrazza P; Gabriele D;

Unusual osteonecrosis caused by radiochemotherapy. A case in La Radiologia medica

1999
ASL Biella

Moro G; Ciambellotti E;

Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study. in Cancer chemotherapy and pharmacology / Cancer Chemother Pharmacol. 1998;41(4):333-8. doi: 10.1007/s002800050747.

1998
AOU San Luigi di Orbassano
ASL Biella

Dogliotti L; Danese S; Berruti A; Zola P; Buniva T; Bottini A; Richiardi G; Moro G; Farris A; Baù MG; Porcile G;

Prognostic factors in metastatic breast cancer patients obtaining objective response or disease stabilization after first-line chemotherapy with epirubicin. Evidence for a positive effect of maintenance hormonal therapy on overall survival in Anticancer Research

1997
ASL Biella

Berruti A; Zola P; Buniva T; Baú MG; Farris A; Sarobba MG; Bottin A; Tampellini M; Durando A; Destefanis M; Monzeglio C; Moro G; Sussio M; Perroni D; Dogliotti L;

Serum levels of four tumour markers during viral hepatitis in Minerva Medica

1987
ASL Biella

Coda C; Lanza E; Ciambellotti E; Cartia GL; Moro G;

Synchronous and metachronous lung carcinomas related to malignant primary tumours at other sites in Minerva Medica

1985
ASL Biella

Ciambellotti E; Moro G; Lanza E;

Malignant tumours preceding or following cases of breast cancer in Minerva Medica

1985
ASL Biella

Ciambellotti E; Moro G; Cartia GL; Coda C;